Navrogen
Biotechnology, Life Science, Pharmaceutical
Founded in 1/1/17
Philadelphia, Pennsylvania, United States
For Profit
About Navrogen
Navrogen Inc. is a biopharmaceutical company focused on the targeted treatment of cancer. Navrogen is currently working on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells which inhibit the cancer-fighting humoral immune system.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 6200000 USD
- Last Funding: 3000000 USD (Seed)
- Funding Status: Seed
Technology Stack
Navrogen actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Life Science, Pharmaceutical
Headquarters: Philadelphia, Pennsylvania, United States